STOCK TITAN

FortuneX cuts WT Realty merger equity value to $525M

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

FortuneX Acquisition Corp. (FXAC) agreed to combine with WT Realty Group Inc. FortuneX would domesticate as a Delaware corporation and be renamed FortuneX Realty Group Holdings Inc.; its merger subsidiary would merge into WT Realty, which would survive as a wholly owned subsidiary. Under the amended agreement, WT Realty stockholders would receive 52,500,000 PubCo shares, representing a $525 million agreed equity value, versus 60,000,000 shares and $600 million originally. The fixed consideration is not adjusted for cash, debt, working capital or similar items.

Closing remains subject to registration effectiveness, shareholder and stockholder approvals, Nasdaq listing approval and other conditions, and is not assured. FortuneX has until May 26, 2027 to complete a business combination. As of September 30, 2026, it reported $506,057 in cash, $628,777 in working capital and $88,189,510 in Trust Account investments. Net income was $407,669 for the three months ended September 30, 2026, while the company had generated no operating revenue. Management said its resources were insufficient to sustain operations for a reasonable period and that conditions raised substantial doubt about its ability to continue as a going concern.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Going-concern finding cites insufficient resources for one year.

Filing Explained

The expense cap is conditional, not all-in: it applies only to covered costs and a qualifying closing.

Under the still-pending WT Realty combination, WT Realty agreed to provide up to $2,431,250 in non-interest-bearing loans to the Sponsor; they become due at Closing and, at the Sponsor’s election, may be repaid in cash or by issuing or transferring equity securities, including Founder Shares, so cash repayment is not assured.

As of September 30, 2026, the Sponsor had received $1,431,250, and FortuneX had recorded no liability; FortuneX and the Sponsor are jointly and severally liable for the loans.

The agreement permits repayment through issuance or transfer of equity securities; only newly issued shares would increase the share count and reduce existing holders’ percentage ownership.

Separately, WT Realty has an option during the 12 months after Closing to buy all or part of the Sponsor Securities for an aggregate $4.0 million.

The option covers Sponsor securities including Founder Shares, Private Placement Units, and Sponsor promissory notes.

If Closing occurs on or before May 26, 2027, covered transaction expenses generally face a $1.5 million cap; specified deferred legal, advisory, and other professional fees contingent on Closing are excluded, and covered excess is borne solely by FortuneX or the Sponsor.

Merger consideration 52,500,000 shares Shares of PubCo common stock for WT Realty stockholders under the amended agreement.
Agreed equity value $525 million WT Realty value under the amended agreement, based on a $10.00 reference price.
Cash $506,057 As of September 30, 2026.
Working capital $628,777 As of September 30, 2026.
Trust Account investments $88,189,510 As of September 30, 2026.
Net income $407,669 For the three months ended September 30, 2026.
Business-combination deadline May 26, 2027 FortuneX’s Combination Period deadline.
Sponsor-securities option price $4.0 million Aggregate price for WT Realty’s option to purchase all or part of Sponsor Securities following Closing.
temporary equity financial
"classified as temporary equity upon the completion of the IPO"
Equity-like securities that accounting rules require to be reported separately from permanent shareholders’ equity because the holder can force or the issuer is obligated to settle them in cash or other assets (or they will be settled on a specified date). Examples include mandatorily redeemable shares and certain convertible instruments with required cash settlement; on the balance sheet they appear between liabilities and shareholders’ equity (often called mezzanine or temporary equity) rather than as part of common equity.
deferred underwriting fee financial
"a deferred underwriting fee equal to 5.0% of the gross proceeds"
cashless basis technical
"holders may exercise the warrants on a cashless basis"
An agreement executed on a cashless basis lets a holder convert or exercise a security (like options, warrants, or conversion rights) without paying money upfront; instead the holder receives a smaller number of shares equal in value to what the cash would have purchased. Think of trading a coupon for fewer slices of a cake rather than handing over cash for the full slice. For investors, it affects how much ownership and dilution occur and avoids immediate cash outlays.
redemption value financial
"ordinary shares subject to possible redemption are presented at redemption value"
going concern financial
"conditions raise substantial doubt about the Company’s ability to continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is FXAC’s proposed merger consideration for WT Realty?

Under the October 13, 2026 amendment, WT Realty stockholders would receive 52,500,000 PubCo common shares, representing an agreed equity value of $525 million at a $10.00 reference price. The original agreement provided for 60,000,000 shares and a $600 million agreed equity value.

When does FXAC’s business-combination period end, and what happens if no deal closes?

FortuneX’s Combination Period ends on May 26, 2027. If it does not complete a business combination by then, it must cease operations, redeem public shares using the Trust Account funds as described in its governing documents, and proceed toward dissolution and liquidation, subject to applicable requirements.

What option does WT Realty have over FortuneX sponsor securities?

For the 12-month period following Closing, WT Realty may purchase all or part of the Sponsor Securities for an aggregate purchase price of $4.0 million. The Sponsor is subject to specified transfer restrictions during the option period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false --02-28 2026 Q2 0002121703 0002121703 2026-04-01 2026-09-30 0002121703 CIK0002121703:UnitsEachConsistingOfOneOrdinaryShareAndOnehalfOfOneWarrantMember 2026-04-01 2026-09-30 0002121703 CIK0002121703:OrdinarySharesParValue0.0001Member 2026-04-01 2026-09-30 0002121703 CIK0002121703:WarrantsEachExercisableForOneOrdinaryShareAtExercisePriceOf11.50PerShareMember 2026-04-01 2026-09-30 0002121703 2026-11-16 0002121703 2026-09-30 0002121703 2026-03-31 0002121703 2026-07-01 2026-09-30 0002121703 CIK0002121703:RedeemableOrdinaryShareMember 2026-07-01 2026-09-30 0002121703 CIK0002121703:RedeemableOrdinaryShareMember 2026-04-01 2026-09-30 0002121703 CIK0002121703:NonRedeemableOrdinaryShareMember 2026-07-01 2026-09-30 0002121703 CIK0002121703:NonRedeemableOrdinaryShareMember 2026-04-01 2026-09-30 0002121703 us-gaap:CommonStockMember 2026-03-31 0002121703 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0002121703 us-gaap:RetainedEarningsMember 2026-03-31 0002121703 us-gaap:CommonStockMember 2026-06-30 0002121703 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0002121703 us-gaap:RetainedEarningsMember 2026-06-30 0002121703 2026-06-30 0002121703 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0002121703 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0002121703 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0002121703 2026-04-01 2026-06-30 0002121703 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0002121703 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0002121703 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0002121703 us-gaap:CommonStockMember 2026-09-30 0002121703 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0002121703 us-gaap:RetainedEarningsMember 2026-09-30 0002121703 us-gaap:IPOMember 2026-05-01 2026-05-26 0002121703 us-gaap:IPOMember 2026-05-26 0002121703 us-gaap:PrivatePlacementMember 2026-05-01 2026-05-26 0002121703 us-gaap:PrivatePlacementMember 2026-05-26 0002121703 us-gaap:OverAllotmentOptionMember 2026-05-01 2026-05-26 0002121703 us-gaap:OverAllotmentOptionMember 2026-05-26 0002121703 us-gaap:OverAllotmentOptionMember 2026-05-02 2026-05-27 0002121703 us-gaap:OverAllotmentOptionMember 2026-05-27 0002121703 us-gaap:OverAllotmentOptionMember 2026-05-03 2026-05-29 0002121703 us-gaap:OverAllotmentOptionMember 2026-05-29 0002121703 us-gaap:IPOMember 2026-05-29 0002121703 us-gaap:PrivatePlacementMember 2026-05-29 0002121703 us-gaap:IPOMember CIK0002121703:UnderwriterMember 2026-05-01 2026-05-26 0002121703 2026-10-13 0002121703 2027-05-26 0002121703 us-gaap:USTreasurySecuritiesMember 2026-09-30 0002121703 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2026-09-30 0002121703 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member 2026-09-30 0002121703 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel3Member 2026-09-30 0002121703 CIK0002121703:RedeemableOrdinarySharesMember 2026-07-01 2026-09-30 0002121703 CIK0002121703:NonRedeemableOrdinarySharesMember 2026-07-01 2026-09-30 0002121703 CIK0002121703:RedeemableOrdinarySharesMember 2026-04-01 2026-09-30 0002121703 CIK0002121703:NonRedeemableOrdinarySharesMember 2026-04-01 2026-09-30 0002121703 us-gaap:IPOMember 2026-05-04 2026-05-26 0002121703 us-gaap:IPOMember 2026-05-03 2026-05-29 0002121703 CIK0002121703:FounderSharesMember 2026-02-01 2026-02-28 0002121703 CIK0002121703:FounderSharesMember 2026-02-28 0002121703 2026-02-01 2026-02-28 0002121703 CIK0002121703:UnderwritingAgreementMember 2026-04-01 2026-09-30 0002121703 2026-02-28 0002121703 CIK0002121703:PublicSharesMember 2026-09-30 0002121703 CIK0002121703:PrivateSharesMember 2026-09-30 0002121703 CIK0002121703:WarrantsMember 2026-04-01 2026-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarter ended September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from          to          

 

Commission file number: 001-43307

 

FortuneX Acquisition Corporation

(Exact Name of Registrant as Specified in Its Charter)

 

Cayman Islands   N/A
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

1185 Avenue of the Americas, 3rd Fl.

New York, NY 10036

(Address of principal executive offices)

 

Tel: (212) 612-1400

(Issuer’s telephone number)

 

Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒   No ☐

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging Growth Company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒   No ☐

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one ordinary share, and one-half of one warrant   FXACU   The Nasdaq Stock Market LLC
Ordinary Shares, par value $0.0001   FXAC   The Nasdaq Stock Market LLC
Warrants, each exercisable for one ordinary share at an exercise price of $11.50 per share   FXACW   The Nasdaq Stock Market LLC

 

As of November 16, 2026, 12,631,929 Ordinary Shares, including Ordinary Shares underlying the units, par value $0.0001 per share, were issued and outstanding.

 

 

 

 

 

 

FortuneX Acquisition Corporation

 

FORM 10-Q FOR QUARTER ENDED SEPTEMBER 30, 2026

 

TABLE OF CONTENTS

 

        Page
PART I – FINANCIAL INFORMATION   1
     
Item 1.   Financial Statements   1
    Condensed Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and March 31, 2026   1
    Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended September 30, 2026   2
    Unaudited Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three and Six Months Ended September 30, 2026   3
    Unaudited Condensed Consolidated Statement of Cash Flows for the Six Months Ended September 30, 2026   4
    Notes to Unaudited Condensed Consolidated Financial Statements   5
Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   20
Item 3.   Quantitative and Qualitative Disclosures About Market Risk   26
Item 4.   Controls and Procedures   26
         
PART II – OTHER INFORMATION   28
     
Item 1.   Legal Proceedings   28
Item 1A.   Risk Factors   28
Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds   28
Item 3.   Defaults Upon Senior Securities   28
Item 4.   Mine Safety Disclosures   28
Item 5.   Other Information   28
Item 6.   Exhibits   29
         
SIGNATURES   30

 

i

 

 

PART I – FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

FORTUNEX ACQUISITION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

 

                 
    September 30,
2026
    March 31,
2026
 
    (Unaudited)     (Audited)  
Assets:                
Current Assets                
Cash   $ 506,057     $ -  
Prepaid expenses     166,055       -  
Total Current Assets     672,112       -  
                 
Investments held in Trust Account     88,189,510       -  
Prepaid Insurance - Noncurrent     69,375       -  
Deferred offering costs     -       25,000  
Total Assets   $ 88,930,997     $ 25,000  
                 
Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity                
Current Liabilities                
Accounts payable and accrued expenses     43,335       4,141  
Total Current Liabilities     43,335       4,141  
                 
Deferred underwriting fee payable     4,312,500       -  
Total Liabilities     4,355,835       4,141  
                 
Commitments and Contingencies – see Note 6                
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 8,625,000 shares subject to possible redemption     88,189,510       -  
                 
Shareholders’ (Deficit) Equity                
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,006,929 and 3,694,429 shares issued and outstanding as of September 30, 2026 and March 31, 2026, respectively (excluding 8,625,000 shares subject to possible redemption)     401       370  
Additional paid-in capital     -       24,630  
Accumulated deficit     (3,614,749 )     (4,141 )
Total Shareholders’ (Deficit) Equity     (3,614,348 )     20,859  
Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ (Deficit) Equity   $ 88,930,997     $ 25,000  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

1

 

 

FORTUNEX ACQUISITION CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

                 
    For the
Three Months Ended
September 30,
2026
    For the
Six Months Ended
September 30,
2026
 
General and administrative expenses   $ 384,781     $ 492,466  
Loss from operations     (384,781 )     (492,466 )
                 
Other income:                
Interest income     2,577       5,836  
Interest earned on investments held in Trust Account     789,873       1,077,010  
Net income   $ 407,669     $ 590,380  
                 
Weighted average shares outstanding, ordinary shares subject to possible redemption - basic and diluted     8,625,000       5,967,213  
Basic and diluted net income per share, ordinary shares subject to possible redemption   $ 0.03     $ 0.06  
Weighted average shares outstanding, non-redeemable ordinary shares - basic and diluted     4,006,929       3,911,055  
Basic and diluted net income per share, non-redeemable ordinary shares   $ 0.03     $ 0.06  

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

FORTUNEX ACQUISITION CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT)

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2026

 

                                         
    Ordinary Shares     Additional
Paid-in
    Accumulated     Total
Shareholders’
Equity
 
    Shares     Amount     Capital     (Deficit)     (Deficit)  
Balance–March 31, 2026     3,694,429     $ 370     $ 24,630     $ (4,141 )   $ 20,859  
Issuance of Private Placement Units (including over-allotment)     312,500       31       3,124,969       -       3,125,000  
Issuance of Public warrants net of issuance costs     -       -       1,259,973       -       1,259,973  
Reversal of over-allotment option liability     -       -       102,787       -       102,787  
Accretion of carrying value of ordinary shares subject to possible redemption to redemption value     -       -       (7,636,337 )     -       (7,636,337 )
Accretion of additional paid-in capital to accumulated deficit     -       -       3,123,978       (3,123,978 )     -  
Remeasurement of carrying value to redemption value (trust interest)     -       -       -       (287,137 )     (287,137 )
Net Income     -       -       -       182,711       182,711  
Balance–June 30, 2026 (Unaudited)     4,006,929     $ 401     $ -     $ (3,232,545 )   $ (3,232,144 )
Remeasurement of carrying value to redemption value (trust interest)   -    -    -    (789,873)   (789,873)
Net Income   -    -    -    407,669    407,669 
Balance–September 30, 2026 (Unaudited)   4,006,929   $401   $-   $(3,614,749)  $(3,614,348)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3

 

 

FORTUNEX ACQUISITION CORPORATION

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

 

         
    For the
Six Months Ended
September 30,
2026
 
Cash Flows from Operating Activities:        
Net Income   $ 590,380  
Adjustments to reconcile net income to net cash used in operating activities:        
Interest earned on investments held in Trust Account     (1,077,010 )
Changes in operating assets and liabilities:        
Prepaid expenses and prepaid insurance     (235,430 )
Accounts payable and accrued expenses     39,194  
Net cash used in operating activities     (682,866 )
         
Cash Flows from Investing Activities:        
Purchase of investments held in Trust Account     (87,112,500 )
Net cash used in investing activities     (87,112,500 )
         
Cash Flows from Financing Activities:        
Proceeds from initial public offering and over-allotment     86,250,000  
Proceeds from sale of private placement units     3,125,000  
Payment of underwriter compensation     (284,625 )
Payment of offering costs     (724,092 )
Advances from related party     101,240  
Repayment of related party advances     (166,100 )
Net cash provided by financing activities     88,301,423  
         
Net change in cash     506,057  
Cash, beginning of period     -  
Cash, end of period   $ 506,057  
         
Supplemental disclosure of noncash investing and financing activities:        
Deferred offering costs charged to shareholders’ equity upon closing of the IPO   $ 25,000  
Offering costs paid by the Sponsor and recorded as related party advances   $ 64,860  
Accretion of ordinary shares subject to possible redemption to redemption value   $ 7,636,337  

 

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

 

4

 

 

FORTUNEX ACQUISITION CORPORATION

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1 — Organization, Business Operations

 

FortuneX Acquisition Corporation (“FortuneX” or the “Company”) is a newly organized blank check company incorporated under the laws of the Cayman Islands with limited liability on February 16, 2026. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (“Business Combination”). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

 

As of September 30, 2026, the Company had not commenced any operations. For the period from February 16, 2026 (inception) through September 30, 2026, the Company’s efforts have been limited to organizational activities as well as activities related to completing the initial public offering (“IPO”) described below, and subsequent to the IPO, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of dividend and/or interest income from the proceeds derived from the IPO and sale of Private Placement Units (as defined below). The Company has selected March 31 as its fiscal year end.

 

The Company’s sponsor is FortuneX Investment Partners Limited (the “Sponsor”), a British Virgin Islands business company. The Company’s ability to commence operations is contingent upon obtaining adequate financial resources through the IPO (see Note 3) and Private Placement (as defined below) to the initial shareholder (see Note 4).

 

The registration statement for the Company’s IPO was declared effective on May 19, 2026. On May 26, 2026, the Company consummated its IPO of 7,500,000 units (the “Public Units”) at a price of $10.00 per unit, generating gross proceeds of $75,000,000. Simultaneously with the closing of the IPO, the Company sold to its Sponsor 297,500 units at $10.00 per unit (the “Private Placement Units”) in a private placement generating total gross proceeds of $2,975,000, which is described in Note 4.

 

The Company granted the underwriters a 45-day option to purchase up to an additional 1,125,000 Units (the “Option Units”) at $10.00 per unit to cover over-allotments, if any. On May 27, 2026, the underwriters exercised their over-allotment option in full to purchase an additional 1,125,000 Option Units at $10.00 per unit, generating additional gross proceeds of $11,250,000. The over-allotment was closed on May 29, 2026. Simultaneously with the closing of the over-allotment option, the Company consummated the private placement of an additional 15,000 private placement units to the Sponsor at a price of $10.00 per unit, generating gross proceeds of $150,000. As a result, the Company sold an aggregate of 8,625,000 Public Units and 312,500 private placement units.

 

Upon the underwriters’ full exercise of the over-allotment option, transaction costs amounted to $5,513,864, consisting of $4,597,125 underwriting commissions, $284,625 of which was paid in cash at the closing date of the IPO, the remaining $4,312,500 deferred commission will be paid upon the closing of a Business Combination solely from amounts remaining in the Trust Account, and $916,739 of legal and other offering costs. At the IPO date, cash of $1,102,515 was held outside of the Trust Account (as defined below) and is available for working capital purposes.

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on interest earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”).

 

5

 

 

A total of $87,112,500 ($10.10 per Unit) of the net proceeds from the sales of Public Units in the IPO, the Option Units and the Private Placements on May 26, 2026 and May 29, 2026, was deposited into a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company as trustee (the “Trust Account”). The funds held in the Trust Account are invested only in U.S. government treasury bills with a maturity of 185 days or less, or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act and investing solely in U.S. government treasury obligations. The funds held in the Trust Account will be released only upon the earlier of: (i) the consummation of a Business Combination, or (ii) the Company’s failure to complete a Business Combination within the applicable period of time.

 

The Company will provide its holders of the outstanding Public Shares (the “Public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.10 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its franchise and income tax obligations). The Public Shares subject to redemption were recorded at a redemption value and classified as temporary equity upon the completion of the IPO in accordance with the Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”

 

If the Company seeks shareholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Company’s Sponsor and any of the Company’s officers or directors that may hold Founder Shares (as defined in Note 5) (the “Initial Shareholders”) and the underwriters have agreed (a) to vote their Founder Shares, Private Shares (as defined in Note 4), and any Public Shares purchased during or after the IPO (other than Public Shares purchased outside of a redemption offer which may not be voted in favor of approving the business combination transaction in accordance with the requirements of Rule 14e-5 under the Exchange Act and any SEC interpretations or guidance relating thereto) in favor of approving a Business Combination and (b) not to convert any shares (including the Founder Shares) in connection with a shareholder vote to approve, or sell the shares to the Company in any tender offer in connection with, a Business Combination.

 

Notwithstanding the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the amended and restated memorandum and articles of association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

 

The Initial Shareholders have agreed (a) to waive their redemption rights with respect to the Founder Shares, Private Shares, and Public Shares held by them in connection with the completion of a Business Combination and (b) not to propose, or vote in favor of, an amendment to the amended and restated memorandum and articles of association that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public shareholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

 

6

 

 

The Company has 12 months from the consummation of the IPO, or May 26, 2027, to consummate its initial business combination (“Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account including interest (which interest shall be net of taxes payable), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

 

The Sponsor and the other Initial Shareholders have agreed to waive their rights to liquidating distributions from the Trust Account with respect to the Founder Shares, and Private Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or the other Initial Shareholders acquires Public Shares in or after the IPO, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period.

 

In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.10 per public share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of IPO against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims.

 

Merger Agreement

 

On September 18, 2026, FortuneX entered into a Business Combination Agreement (the “BCA”) with WT Realty Group Inc., a Delaware corporation (“WT Realty”), and FortuneX Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of FortuneX (“Merger Sub”). Pursuant to the BCA, among other things, FortuneX will deregister under the Cayman Islands Companies Act (As Revised) and domesticate as a corporation incorporated in the State of Delaware (the “Domestication”), and immediately following the Domestication, Merger Sub will merge with and into WT Realty, with WT Realty surviving as a wholly owned subsidiary of FortuneX (the “Merger” and, together with the Domestication and the other transactions contemplated by the BCA, the “Business Combination”). In connection with the Domestication, FortuneX will be renamed “FortuneX Realty Group Holdings Inc.” (“PubCo”).

 

Merger Consideration

 

At the Domestication Effective Time, each issued and outstanding FortuneX ordinary share, after giving effect to any redemptions, will automatically convert into one share of PubCo Class A common stock. Each outstanding FortuneX warrant will become a warrant to purchase an equal number of shares of PubCo Class A common stock, subject to the same terms and conditions applicable immediately prior to the Domestication.

 

Immediately following the Domestication, Merger Sub will merge with and into WT Realty. Pursuant to the BCA, as amended on October 13, 2026, the aggregate consideration payable to WT Realty securityholders will consist of 52,500,000 shares of PubCo common stock, compared to 60,000,000 shares under the original BCA, representing agreed equity values of WT Realty of $525 million, and $600 million, respectively, based on a reference price of $10.00 per share. The merger consideration is fixed and is not subject to adjustment for cash, indebtedness, net debt, working capital or similar items.

 

7

 

 

Sponsor Loans and Transaction Expenses

 

WT Realty has agreed to provide, or cause to be provided, to FortuneX’s sponsor (the “Sponsor”) non-interest-bearing loans in an aggregate principal amount of $2,431,250. The loans consist of $931,250 released from escrow upon execution of the BCA and three additional loans of $500,000 payable upon (i) execution of the BCA, (ii) initial filing of the Registration Statement with the SEC, and (iii) the earlier of the effectiveness of the Registration Statement and January 5, 2027, respectively. The Sponsor Loans, for which FortuneX and the Sponsor are jointly and severally liable, will become due and payable upon consummation of the Business Combination and will be repaid at Closing, at the Sponsor’s election, either in cash from Available Closing Cash or through the issuance or transfer of equity securities, including Founder Shares, valued at $10.00 per share. As of September 30, 2026, the Sponsor had received $1,431,250 in loans. The Company had not recognized any liability as of that date.

 

If the Closing occurs on or before May 26, 2027, FortuneX transaction expenses payable by PubCo, WT Realty or from Available Closing Cash generally will be subject to a $1.5 million cap, subject to specified exclusions. The SPAC Expense Cap includes D&O tail insurance premiums, administrative services fees and extension-related expenses, but excludes deferred legal, advisory and other professional fees that are contingent upon the consummation of the Business Combination. Any covered transaction expenses exceeding the cap will be borne solely by FortuneX or the Sponsor. The deferred underwriting commission payable pursuant to the Underwriting Agreement is governed exclusively by the applicable provisions of the BCA and is not payable by PubCo, WT Realty or from the proceeds of any Transaction Financing.

 

Covenants and Closing Conditions

 

The BCA contains customary representations, warranties, covenants and agreements, including covenants relating to the conduct of business prior to Closing, preparation and effectiveness of the registration statement, obtaining shareholder and stockholder approvals, required regulatory and third-party consents, Nasdaq listing approval, and restrictions on alternative transactions. FortuneX may seek PIPE investments or other transaction financing with WT Realty’s prior written consent; however, as of the date of the BCA, no commitments for transaction financing had been executed.

 

The consummation of the Business Combination is subject to customary closing conditions, including effectiveness of the registration statement, approval by FortuneX shareholders and WT Realty stockholders, approval of PubCo’s Nasdaq listing application, and satisfaction of applicable Nasdaq initial listing requirements. Additional conditions include the accuracy of each party’s representations and warranties, material compliance with its covenants, absence of a material adverse effect with respect to WT Realty, delivery of required financial statements and other closing documentation, and continued effectiveness of the applicable support agreements.

 

Sponsor Support Agreement and Call Option

 

Concurrently with execution of the BCA, the Sponsor and certain other holders of FortuneX securities entered into a Sponsor Support Agreement, pursuant to which they agreed, among other things, to vote their securities in favor of the Business Combination and related proposals, waive certain redemption and anti-dilution rights, and comply with specified transfer restrictions.

 

The Sponsor Support Agreement also grants WT Realty an option, exercisable during the 12-month period following Closing, to purchase all or a portion of the Sponsor Securities for an aggregate purchase price of $4.0 million. Sponsor Securities include Founder Shares, Private Placement Units, promissory notes held by the Sponsor and securities issued or issuable in respect thereof. The Sponsor is subject to specified restrictions on transferring such securities during the option period.

 

Termination

 

The BCA may be terminated by mutual written consent or under specified circumstances, including failure to obtain the required shareholder approval, certain legal prohibitions, uncured material breaches, or failure to consummate the Business Combination by May 26, 2027 (the “Outside Closing Date”). FortuneX may also terminate the BCA if WT Realty fails to deliver the required PCAOB-audited financial statements by October 30, 2026. Under specified circumstances, a $500,000 termination fee may be payable by the breaching party to the non-breaching party.

 

8

 

 

The BCA was unanimously approved by the boards of directors of FortuneX, WT Realty and Merger Sub. The Business Combination is expected to be consummated following satisfaction or waiver of the applicable closing conditions. There can be no assurance that the Business Combination will be completed.

 

Amendment to Business Combination Agreement

 

On October 13, 2026, FortuneX, WT Realty and Merger Sub entered into a First Amendment to BCA (the “Amendment”). Pursuant to the Amendment, the parties agreed to amend and restate in its entirety the definition of “Aggregate Merger Consideration” in Section 1.1 of the BCA to reduce the aggregate merger consideration payable to WT Realty’s stockholders from 60,000,000 shares of PubCo Common Stock, representing an agreed equity value of $600,000,000, to 52,500,000 shares of PubCo Common Stock, being the number of shares equal to the agreed equity value of WT Realty of $525,000,000 divided by the reference price of $10.00 per share. The Aggregate Merger Consideration remains a fixed number of shares and is not subject to any adjustment for cash, indebtedness, net debt, working capital or any similar item, whether before or after the date of the Amendment, nor to any purchase price adjustment, escrow or holdback. Except as expressly amended by the Amendment, the Business Combination Agreement remains in full force and effect in accordance with its terms.

 

Subsidiary

 

On September 15, 2026, FortuneX Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of FortuneX, was formed to merge with and into WT Realty immediately following the Domestication, with WT Realty surviving the Merger as a wholly owned subsidiary of PubCo. The Merger Sub has no principal operations or revenue producing activities.

 

Going Concern Consideration

 

As of September 30, 2026, the Company had $506,057 of cash and a working capital of $628,777. The Company has incurred and expects to continue to incur significant costs in pursuit of the consummation of an initial Business Combination. In addition, the Company currently has until May 26, 2027 (unless the Company extends such period by amending its Amended and Restated Memorandum and Articles of Association) to consummate the initial Business Combination. If the Company does not complete a Business Combination within the prescribed timeline, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards “Codification Subtopic 205-40, Presentation of Financial Statements - Going Concern”, the Company has determined that it has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. Management plans to address this uncertainty through the consummation of the Business Combination with WT Realty and, if necessary, additional financing that may be sought from the Sponsor or other sources, although no such financing is assured. However, the consummation of the Business Combination is subject to conditions outside of the Company’s control, including shareholder and regulatory approvals. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful within the Combination Period. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the date of the issuance of the unaudited condensed consolidated financial statements. Therefore, management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. The financial statements do not include any adjustments that might result from the Company’s inability to continue as a going concern.

 

9

 

 

Note 2 — Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiary, FortuneX Merger Sub Inc. All intercompany balances and transactions have been eliminated upon consolidation. The unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information, as set forth by the Financial Accounting Standards Board (“FASB”), and pursuant to the rules and regulations of the SEC. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. They should be read in conjunction with the Company’s audited financial statements for the period from February 16, 2026 (inception) through March 31, 2026, as included in the Company’s registration statement and related filings with the SEC. The interim results for the three and six months ended September 30, 2026 are not necessarily indicative of the results that may be expected through March 31, 2027 or for any future periods.

 

Emerging Growth Company Status

 

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

 

Use of Estimates

 

In preparing these unaudited condensed consolidated financial statements in conformity with U.S. GAAP, the Company’s management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported expenses during the reporting period.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.

 

10

 

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $506,057 and $0 in cash and cash equivalents as of September 30, 2026 and March 31, 2026, respectively.

 

Investments Held in Trust Account

 

As of September 30, 2026 and March 31, 2026, the Company had $88,189,510 and $0, respectively, in investments held in the Trust Account comprised of money market funds that invest in U.S. government securities.

 

Investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Earnings on investments held in the Trust Account are included in interest earned on investments held in the Trust Account in the accompanying statement of operations. The estimated fair value of investments held in the Trust Account is determined using available market information.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist primarily of money market fund investments held both outside and within the Trust Account. As of September 30, 2026, the Company held $506,057 outside the Trust Account in the Treasury Liquidity Fund and $88,189,510 in the Trust Account, consisting primarily of investments in a U.S. Treasury securities money market fund (MSUXX). Both investments were held in brokerage accounts with Morgan Stanley Smith Barney LLC, a member of the Securities Investor Protection Corporation (SIPC).

 

These money market fund investments are not insured by the Federal Deposit Insurance Corporation (FDIC) and may be eligible for SIPC protection, subject to applicable limits and conditions. As of September 30, 2026, the balances held both outside and within the Trust Account exceeded the standard SIPC protection limit of $500,000 per customer. SIPC protection does not cover losses resulting from market fluctuations. Any loss incurred or lack of access to such funds could have a significant adverse impact on the Company's financial condition, results of operations, and cash flows.

 

Fair Value of Financial Instruments

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

 

The Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a liability in the Company’s principal or most advantageous market in an orderly transaction between market participants on the measurement date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs reflect the entity’s own assumptions based on market data and the entity’s judgments about the assumptions that market participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.

 

  ● Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

  ● Level 2 — Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted intervals.

 

  ● Level 3 — Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little or no market data exists for the assets or liabilities.

 

11

 

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September 30, 2026 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.

 

                               
    September 30,
2026
    Quoted Prices in
Active Markets
(Level 1)
    Significant Other
Observable Inputs
(Level 2)
    Significant Other
Unobservable Inputs
(Level 3)
 
Assets                                
Investments held in Trust Account   $ 88,189,510     $ 88,189,510       -       -  

 

Offering Costs

 

The Company complies with the requirements of FASB ASC Topic 340-10-S99-1, “Other Assets and Deferred Costs – SEC Materials” (“ASC 340-10-S99”) and SEC Staff Accounting Bulletin Topic 5A, “Expenses of Offering”. Offering costs incurred in connection with the IPO totaled $5,513,864, consisting of $284,625 cash underwriting commissions, which were paid in cash at the closing date of the IPO, $4,312,500 deferred underwriting commissions, and $916,739 of legal and other offering costs that are directly related to the IPO and the underwriters’ full exercise of the over-allotment option, and charged to shareholders’ equity upon the completion of the IPO and the over-allotment option.

 

Ordinary Shares Subject to Possible Redemption

 

The Company accounts for its ordinary shares subject to possible redemption in accordance with ASC Topic 480, “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption, if any, are classified as liability instruments and measured at fair value. Conditionally redeemable ordinary shares, including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain future events not solely within the Company’s control, are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity.

 

In accordance with ASC 480-10-S99, the Company classifies its ordinary shares subject to redemption outside of permanent equity because the redemption provisions are not solely within the control of the Company. Given that the 8,625,000 ordinary shares sold as part of the Units in the IPO were issued with other freestanding instruments (i.e., warrants), the initial carrying value of ordinary shares classified as temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting period.

 

The Company has elected to recognize the changes immediately. The initial accretion and subsequent remeasurements will be treated as deemed dividends and are charged against additional paid-in capital to the extent available, with any excess charged against retained earnings (accumulated deficit). Accordingly, as of September 30, 2026, ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.

 

12

 

 

As of September 30, 2026, the ordinary shares subject to redemption reflected in the balance sheet are reconciled in the following table:

 

       
Gross proceeds from IPO   $ 86,250,000  
Less:        
Proceeds allocated to Public Warrants     (1,259,973 )
Public shares issuance costs     (5,329,150 )
Offering costs allocated to permanent equity     (184,714 )
Plus:        
Accretion of carrying value to redemption value     7,636,337  
Remeasurement of carrying value to redemption value (trust interest)     287,137  
Ordinary shares subject to possible redemption, June 30, 2026   $ 87,399,637  
Remeasurement of carrying value to redemption value (trust interest)     789,873  
Ordinary shares subject to possible redemption, September 30, 2026   $ 88,189,510  

 

Net Income (Loss) Per Ordinary Share 

 

The Company complies with the accounting and disclosure requirements of FASB ASC 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as redeemable ordinary shares (the Public Shares) and non-redeemable ordinary shares (the Founder Shares, the Private Placement Shares). Net income (loss) per ordinary share is calculated using the two-class method and is computed by dividing net income (loss), allocated on a pro rata basis between the two classes based on the weighted average number of shares of each class outstanding during the period, by the weighted average number of ordinary shares outstanding for each class. The Company has elected to treat only the portion of the periodic adjustment to the carrying amount of the redeemable shares that reflects a redemption in excess of fair value like a dividend. As the redemption value of the redeemable shares approximates fair value, no such adjustment was required and income or loss allocable to each class of ordinary shares has not been adjusted for the accretion of carrying value to redemption value.

 

The calculation of diluted net income (loss) per ordinary share does not consider the effect of the warrants issued in connection with the IPO and the Private Placement, since the exercise of the warrants are contingent upon the occurrence of future events. As of September 30, 2026, the Company did not have any other dilutive securities or contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the period presented.

 

        
   Three Months Ended
September 30,
2026
   Six Months Ended
September 30,
2026
 
Net income  $407,669   $590,380 

 

                          
  

Three Months Ended
September 30,
2026

    Six Months Ended
September 30,
2026
 
  

Redeemable
Ordinary
Shares

  

Non-redeemable
Ordinary
Shares

    Redeemable
Ordinary
Shares
    Non-redeemable
Ordinary
Shares
 
Basic and diluted net income per ordinary share                          
Numerator:                          
Allocation of net income  $278,354   $129,315    $ 356,634     $ 233,746  
                           
Denominator:                          
Basic and diluted weighted average shares outstanding   8,625,000    4,006,929      5,967,213       3,911,055  
Basic and diluted net income per ordinary share  $0.03   $0.03    $ 0.06     $ 0.06  

 

13

 

 

Warrant Accounting

 

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrants’ specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.

 

As the warrants issued upon the closing of the IPO and sale of Private Placement Units meet the criteria for equity classification under ASC 815, the warrants are classified as equity. As of September 30, 2026, there were 4,312,500 Public Warrants and 156,250 Private Warrants issued and outstanding.

 

Income Taxes

 

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statements recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements.

 

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2026 and March 31, 2026. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

 

There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman Islands federal income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed consolidated financial statements.

 

Recent Accounting Pronouncements

 

In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the unaudited financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

 

14

 

 

Note 3 — Initial Public Offering

 

On May 26, 2026 and May 29, 2026, the Company consummated its IPO of 7,500,000 Public Units and the over-allotment of 1,125,000 Option Units at a price of $10.00 per unit, generating gross proceeds of $86,250,000. Each unit consists of one ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share, subject to adjustment, terms and limitations as provided herein. Only whole warrants are exercisable. Each Public Warrant will become exercisable 30 days after the completion of the initial Business Combination and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation. The Company will not issue fractional shares upon exercise of the warrant, as disclosed in Note 7.

 

Note 4 — Private Placement

 

Simultaneously with the closing of the IPO on May 26, 2026 and the over-allotment option on May 29, 2026, the Sponsor purchased an aggregate of 312,500 Private Placement Units at a price of $10.00 per unit, for an aggregate purchase price of $3,125,000.

 

Each Private Unit consists of one ordinary share (“Private Share”) and one-half of one redeemable warrant (“Private Warrant”). Each whole Private Warrant entitles the holder thereof to purchase one ordinary share at a price of $11.50 per full share, subject to adjustment, terms and limitations as provided herein. The proceeds from the Private Placement Units were added to the proceeds from the IPO which were deposited in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units and all underlying securities will expire worthless. The Private Placement Units and the underlying securities may not be transferred, assigned or sold until 30 days after the completion of the Company’s initial Business Combination, subject to certain limited exceptions.

 

Note 5 — Related Party Transactions

 

Founder Shares

 

On February 28, 2026, the Company entered into a subscription agreement with the Sponsor for the purchase of 3,694,429 ordinary shares for an aggregate purchase price of $25,000, or approximately $0.0068 per share. The Founder Shares included up to 482,143 shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full, so that the Sponsor will beneficially own 30% of the Company’s issued and outstanding shares after the IPO (excluding the Private Placement Units and assuming the Sponsor does not purchase any Public Units in the IPO).

 

As of September 30, 2026, there were 3,694,429 Founder Shares issued and outstanding; no Founder Shares were subject to forfeiture as a result of the underwriter’s full exercise of its over-allotment option on May 27, 2026.

 

The Initial Shareholders have agreed, subject to certain limited exceptions, not to transfer, assign or sell any Founder Shares until the earlier of: (i) six months after the completion of the Company’s initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after its initial Business Combination that results in all public shareholders having the right to exchange their ordinary shares for cash, securities or other property. The Initial Shareholders have also agreed not to transfer any ownership interest in the private placement units, except to permitted transferees, until at least 30 days following the completion of the initial Business Combination.

 

15

 

 

Advance — Related Party

 

In connection with the closing of the IPO, the Company provided $185,000 to the Sponsor as funding for the purchase of Directors and Officers Liability (“D&O”) insurance which was recorded as Advance — related party. As a result of the Sponsor’s purchase of D&O Liability insurance for the policy period from May 21, 2026 through May 21, 2028, no amount was outstanding under Advance — related party as of September 30, 2026. The premium is recorded as prepaid insurance and amortized over the policy term, of which $92,500 is included in prepaid expenses and $69,375 is presented as prepaid insurance – noncurrent as of September 30, 2026.

 

Promissory Note — Related Party

 

On February 28, 2026, the Sponsor agreed to loan the Company up to an aggregate amount of $200,000 to be used, in part, for transaction costs incurred in connection with the IPO (the “Promissory Note”). The Promissory Note is unsecured, interest-free and due on the date on which the Company closes the IPO. The outstanding balance under the Promissory Note was settled in connection with the closing of the IPO and the underwriters’ exercise of the over-allotment option out of the offering proceeds not held in the Trust Account and amounts due from the Sponsor. As of September 30, 2026 and March 31, 2026, no amount was outstanding under the promissory note.

 

Working Capital Loans

 

In order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company’s officers and directors, or their affiliates or designees may, but are not obligated to, loan the Company funds from time to time. If the Company completes its initial Business Combination, it will repay such loaned amounts. If the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such amounts, but no proceeds from the Trust Account will be used for such repayment. Up to $1,500,000 of such working capital loans (“Working Capital Loans”) may be convertible into private placement units, at a price of $10.00 per unit at the option of the lender, upon consummation of its initial Business Combination. The units would be identical to the Private Placement Units.

 

As of September 30, 2026 and March 31, 2026, the Company had no borrowings under the Working Capital Loans.

 

Administrative Services Agreement

 

The Company entered into an Administrative Services Agreement with the Sponsor on February 28, 2026, commencing on May 19, 2026, the effective date of the registration statement for the IPO, through the earlier of the consummation of the Company’s initial Business Combination or the Company’s liquidation. Pursuant to the agreement, the Company agreed to pay the Sponsor $15,000 per month for office space and administrative and support services. For the three and six months ended September 30, 2026, $45,000 and $65,320, respectively, in administrative services fees were incurred. As of September 30, 2026, the Company recorded a prepayment of $18,170 as part of its prepaid expenses on the accompanying unaudited condensed consolidated balance sheet.

 

Note 6 — Commitments and Contingencies

 

Risks and Uncertainties

 

Various social and political circumstances in the U.S. and around the world (including rising trade tensions between the U.S. and China, and other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries), may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide.

 

As a result of these circumstances and the ongoing global conflicts and/or other future global conflicts, the Company’s ability to consummate a Business Combination, or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely affected. In addition, the Company’s ability to consummate a transaction may be dependent on the ability to raise equity and debt financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity in third-party financing being unavailable on terms acceptable to the Company or at all.

 

16

 

 

The specific impact of these matters on the Company’s financial position, results of operations, liquidity or ability to complete a Business Combination is not currently determinable. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

Registration Rights

 

The holders of the Founder Shares issued and outstanding as of May 21, 2026, as well as the holders of the Private Placement Units and any shares of the Company’s insiders, officers, directors or their affiliates may be issued in payment of working capital loans made to the Company (and any shares of ordinary shares issuable upon exercise of the underlying private warrants), will be entitled to registration rights pursuant to a registration rights agreement dated May 21, 2026. The holders of a majority of these securities are entitled to make demands that the Company register such securities. Both the holders of the Founder Shares and the holders of the private placement units as well as shares issued in payment of working capital loans made to the Company, if applicable, will have the ability to elect to exercise these registration rights at any time after the consummation of an initial business combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the consummation of an initial business combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Underwriting Agreement

 

The Company has granted Polaris Advisory Partners (“PAP”), the representative of the underwriters, a 45-day option from the date of the consummation of the IPO to purchase up to 1,125,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. On May 27, 2026, the underwriter exercised its over-allotment option in full, and the issuance and sale of the Option Units closed on May 29, 2026.

 

The underwriters are entitled to an underwriting discount of 0.33% of the gross proceeds of the IPO and over-allotment, or $284,625, which was paid upon the closing of the IPO and over-allotment. In addition, PAP is entitled to a deferred underwriting fee equal to 5.0% of the gross proceeds of the IPO and over-allotment, or $4,312,500, which will be payable upon the consummation of the Company’s initial Business Combination from the amounts remaining in the Trust Account following all properly submitted shareholder redemption requests, subject to the terms of the Underwriting Agreement.

 

On July 1, 2026, the Company entered into Amendment No. 1 to the Underwriting Agreement with PAP, the representative of the underwriters, to amend certain terms of the Underwriting Agreement related to the Company’s initial public offering, including provisions regarding the “Firm Units” and “Option Units”, the deferred underwriting discount, the private placement units and related proceeds, administrative services and offering expenses, the Representative’s right of first refusal, and acknowledgements regarding the Trust Account.

 

Right of First Refusal

 

The Company has granted PAP a right of first refusal for a period commencing from the consummation of the IPO until the earlier of (i) 10 months after the consummation of the initial business combination (or the liquidation of the Trust Account in the event that the Company fails to consummate its initial business combination within the prescribed time period) or (ii) 36 months after the consummation of the IPO in accordance with FINRA Rule 5110(g)(6)(A) to act as lead financial advisor, capital markets advisor, underwriter and/or private placement agent in connection with any initial business combination or in connection with any financing that occurs between the closing of the IPO and the date that is the earlier of (i) 10 months after the closing of the initial business combination or (ii) 36 months after the consummation of the IPO.

 

Note 7 — Shareholders’ (Deficit) Equity

 

Ordinary shares — The Company’s Post-offering Memorandum and Articles of Association is authorized to issue up to 500,000,000 ordinary shares, par value $0.0001 per share. Holders of ordinary shares are entitled to one vote for each share held on all matters to be voted on by shareholders, except as required by law. On February 28, 2026, the Sponsor subscribed for 3,694,429 ordinary shares for an aggregate purchase price of $25,000.

 

17

 

 

In connection with the IPO and full exercise of the underwriters’ over-allotment option, the Company issued 312,500 private placement units to the Sponsor. As of September 30, 2026, the Company had 4,006,929 non-redeemable ordinary shares issued and outstanding, excluding 8,625,000 ordinary shares subject to possible redemption. As of March 31, 2026, there were 3,694,429 ordinary shares issued and outstanding, of which an aggregate of up to 482,143 shares are subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full, so that the Sponsor will own 30% of the issued and outstanding shares after the IPO (assuming the Sponsor does not purchase any public units in the IPO and excluding the Private Shares underlying the Private Placement Units). As a result of the underwriter’s full exercise of its over-allotment option on May 27, 2026, no shares are subject to forfeiture.

 

Warrants — As of September 30, 2026, there were 4,312,500 Public Warrants and 156,250 Private Warrants outstanding. As of March 31, 2026, there were no warrants outstanding. Each whole public warrant entitles the registered holder to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, commencing 30 days after the completion of the initial Business Combination, provided that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless a holder purchase at least two units, such holder will not be able to receive or trade a whole warrant. In addition, if the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per ordinary share, the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds available for the funding of the initial business combination on the date of consummation of the initial business combination (net of redemptions), and the Fair Market Value of the ordinary shares, as defined in the warrant agreement, is below $9.20 per share, the exercise price of the warrants will be adjusted to equal 115% of the Fair Market Value. The warrants will expire five years after the completion of the Company’s initial business combination, at 5:00 p.m., New York City time, or earlier upon liquidation of the Trust Account.

 

The Company will not be obligated to deliver any ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of ordinary shares issuable upon exercise of the warrants is then effective and a current prospectus relating to those ordinary shares is available, subject to the Company satisfying its obligations with respect to registration, or a valid exemption from registration is available. No warrant will be exercisable unless the issuance of the shares upon such exercise is registered or qualified under the securities laws of the state of residence of the exercising holder, or an exemption from registration is available; provided, however, that holders may exercise the warrants on a cashless basis in accordance with the warrant agreement if the registration statement covering the ordinary shares issuable upon exercise of the warrants has not been declared effective by the 90th day following the completion of the initial Business Combination, or during any other period when the Company fails to maintain an effective registration statement.

 

The Company has agreed that as soon as practicable, the Company will use its best efforts to file with the SEC, a registration statement covering the issuance of ordinary shares issuable upon exercise of the warrants and to cause such registration statement to become effective and maintain its effectiveness and a current prospectus relating to the ordinary shares issuable upon exercise of the warrants until the warrants expire.

 

The Company will not permit the exercise of the Public Warrants unless a registration statement under the Securities Act covering the issuance of the ordinary shares issuable upon exercise of the public warrants is then effective and a current prospectus relating to those ordinary shares is available throughout the exercise period, subject to the cashless exercise provisions of the warrant agreement. If the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws, holders may not be able to exercise their warrants and the warrants may have no value and expire worthless.

 

The Private Warrants are identical to the Public Warrants, except that the Private Warrants and the ordinary shares issuable upon exercise thereof are subject to certain transfer restrictions prior to the completion of the Company’s initial Business Combination, subject to certain permitted transfers as set forth in the warrant agreement.

 

18

 

 

Note 8 — Segment Information

 

ASC Topic 280, “Segment Reporting,” establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker, or group, in deciding how to allocate resources and assess performance. The Company has adopted the guidance in ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in the accompanying financial statements.

 

The Company’s chief operating decision maker has been identified as the Chairman, Chief Executive Officer and Chief Financial Officer (“CODM”), who reviews the assets, operating results and financial metrics for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one operating and reportable segment. The CODM reviews the position of total assets available to assess if the Company has sufficient resources available to discharge its liabilities.

 

The measure of segment assets is reported on the balance sheet as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

 

     
    September 30,
2026
 
Cash   $ 506,057  
Investments held in Trust Account   $ 88,189,510  

 

The CODM reviews the position of total assets as reported on the Company’s balance sheet to assess if the Company has sufficient resources available to discharge its liabilities. The CODM is provided with details of cash and liquid resources available with the Company. The CODM will review the interest that will be earned and accrued on cash held in Trust Account to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account funds while maintaining compliance with the Trust Agreement.

 

The key measure of segment profit or loss reviewed by our CODM is general and administrative expenses. General and administrative expenses include accounting expenses, printing expenses, and regulatory filing fees, none of which are deemed to be significant segment expenses, and are reviewed in aggregate to ensure alignment with budget and contractual obligations. These expenses are monitored to manage and forecast cash available to complete a business combination within the required period.

 

    For the
Three Months Ended
September 30,
2026
    For the
Six Months Ended
September 30,
2026
 
General and administrative expenses   $ 384,781     $ 492,466  

 

Note 9 — Subsequent Events

 

The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date when these financial statements were issued. Based on this review, the Company identified the following subsequent event requiring disclosure.

 

On October 13, 2026, FortuneX, WT Realty and Merger Sub entered into a First Amendment to Business Combination Agreement (the “Amendment”). Pursuant to the Amendment, the parties agreed to amend and restate in its entirety the definition of “Aggregate Merger Consideration” in Section 1.1 of the Business Combination Agreement to reduce the aggregate merger consideration payable to WT Realty’s stockholders from 60,000,000 shares of PubCo Common Stock, representing an agreed equity value of $600,000,000, to 52,500,000 shares of PubCo Common Stock, being the number of shares equal to the agreed equity value of WT Realty of $525,000,000 divided by the reference price of $10.00 per share. The Aggregate Merger Consideration remains a fixed number of shares and is not subject to any adjustment for cash, indebtedness, net debt, working capital or any similar item, whether before or after the date of the Amendment, nor to any purchase price adjustment, escrow or holdback. Except as expressly amended by the Amendment, the Business Combination Agreement remains in full force and effect in accordance with its terms. 

 

19

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

References to the “Company,” “our,” “us” or “we” refer to FortuneX Acquisition Corporation. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited financial statements and the notes related thereto. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors.

 

Special Note Regarding Forward-Looking Statements

 

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s registration statement on Form S-1 and the related prospectus filed with the U.S. Securities and Exchange Commission (the “SEC”). The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

 

Overview

 

We are a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

 

We intend to effectuate our initial business combination using cash from the proceeds of the Initial Public Offering (“IPO” as defined below), and the private placement of the private placement units, the proceeds of the sale of our securities in connection with our initial business combination, our shares, debt or a combination of cash, stock and debt. We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete an initial business combination will be successful.

 

Recent Developments

 

On May 26, 2026, the Company consummated its IPO of 7,500,000 units (the “Public Units”), at a price of $10.00 per unit, generating gross proceeds of $75,000,000. On May 27, 2026, the underwriters exercised their over-allotment option in full, resulting in the issuance of an additional 1,125,000 units at a price of $10.00 per unit, generating additional gross proceeds of $11,250,000. The over-allotment option closed on May 29, 2026.

 

20

 

 

Simultaneously with the closing of the IPO and over-allotment option, the Company consummated a private placement of 297,500 units and an additional 15,000 units to the Sponsor, respectively, at a price of $10.00 per unit, generating gross proceeds of $3,125,000.

 

On July 1, 2026, the Company entered into Amendment No. 1 to the Underwriting Agreement with PAP, the representative of the underwriters, to amend certain terms of the Underwriting Agreement related to the Company’s initial public offering, including provisions regarding the “Firm Units” and “Option Units”, the deferred underwriting discount, the private placement units and related proceeds, administrative services and offering expenses, the Representative’s right of first refusal, and acknowledgements regarding the Trust Account.

 

Merger Agreement

 

On September 18, 2026, FortuneX entered into a Business Combination Agreement (the “BCA”) with WT Realty Group Inc., a Delaware corporation (“WT Realty”), and FortuneX Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of FortuneX (“Merger Sub”). Pursuant to the BCA, among other things, FortuneX will deregister under the Cayman Islands Companies Act (As Revised) and domesticate as a corporation incorporated in the State of Delaware (the “Domestication”), and immediately following the Domestication, Merger Sub will merge with and into WT Realty, with WT Realty surviving as a wholly owned subsidiary of FortuneX (the “Merger” and, together with the Domestication and the other transactions contemplated by the BCA, the “Business Combination”). In connection with the Domestication, FortuneX will be renamed “FortuneX Realty Group Holdings Inc.” (“PubCo”).

 

Merger Consideration

 

At the Domestication Effective Time, each issued and outstanding FortuneX ordinary share, after giving effect to any redemptions, will automatically convert into one share of PubCo Class A common stock. Each outstanding FortuneX warrant will become a warrant to purchase an equal number of shares of PubCo Class A common stock, subject to the same terms and conditions applicable immediately prior to the Domestication.

 

Immediately following the Domestication, Merger Sub will merge with and into WT Realty. Pursuant to the BCA, as amended on October 13, 2026, the aggregate consideration payable to WT Realty securityholders will consist of 52,500,000 shares of PubCo common stock, compared to 60,000,000 shares under the original BCA, representing agreed equity values of WT Realty of $525 million and $600 million, respectively, based on a reference price of $10.00 per share. The merger consideration is fixed and is not subject to adjustment for cash, indebtedness, net debt, working capital or similar items.

 

Sponsor Loans and Transaction Expenses

 

WT Realty has agreed to provide, or cause to be provided, to FortuneX’s sponsor (the “Sponsor”) non-interest-bearing loans in an aggregate principal amount of $2,431,250. The loans consist of $931,250 released from escrow upon execution of the BCA and three additional loans of $500,000 payable upon (i) execution of the BCA, (ii) initial filing of the Registration Statement with the SEC, and (iii) the earlier of the effectiveness of the Registration Statement and January 5, 2027, respectively. The Sponsor Loans, for which FortuneX and the Sponsor are jointly and severally liable, will become due and payable upon consummation of the Business Combination and will be repaid at Closing, at the Sponsor’s election, either in cash from Available Closing Cash or through the issuance or transfer of equity securities, including Founder Shares, valued at $10.00 per share. As of September 30, 2026, the Sponsor had received $1,431,250 in loans. The Company had not recognized any liability as of that date.

 

If the Closing occurs on or before May 26, 2027, FortuneX transaction expenses payable by PubCo, WT Realty or from Available Closing Cash generally will be subject to a $1.5 million cap, subject to specified exclusions. The SPAC Expense Cap includes D&O tail insurance premiums, administrative services fees and extension-related expenses, but excludes deferred legal, advisory and other professional fees that are contingent upon the consummation of the Business Combination. Any covered transaction expenses exceeding the cap will be borne solely by FortuneX or the Sponsor. The deferred underwriting commission payable pursuant to the Underwriting Agreement is governed exclusively by the applicable provisions of the BCA and is not payable by PubCo, WT Realty or from the proceeds of any Transaction Financing.

 

21

 

 

Covenants and Closing Conditions

 

The BCA contains customary representations, warranties, covenants and agreements, including covenants relating to the conduct of business prior to Closing, preparation and effectiveness of the registration statement, obtaining shareholder and stockholder approvals, required regulatory and third-party consents, Nasdaq listing approval, and restrictions on alternative transactions. FortuneX may seek PIPE investments or other transaction financing with WT Realty’s prior written consent; however, as of the date of the BCA, no commitments for transaction financing had been executed.

 

The consummation of the Business Combination is subject to customary closing conditions, including effectiveness of the registration statement, approval by FortuneX shareholders and WT Realty stockholders, approval of PubCo’s Nasdaq listing application, and satisfaction of applicable Nasdaq initial listing requirements. Additional conditions include the accuracy of each party’s representations and warranties, material compliance with its covenants, absence of a material adverse effect with respect to WT Realty, delivery of required financial statements and other closing documentation, and continued effectiveness of the applicable support agreements.

 

Sponsor Support Agreement and Call Option

 

Concurrently with execution of the BCA, the Sponsor and certain other holders of FortuneX securities entered into a Sponsor Support Agreement, pursuant to which they agreed, among other things, to vote their securities in favor of the Business Combination and related proposals, waive certain redemption and anti-dilution rights, and comply with specified transfer restrictions.

 

The Sponsor Support Agreement also grants WT Realty an option, exercisable during the 12-month period following Closing, to purchase all or a portion of the Sponsor Securities for an aggregate purchase price of $4.0 million. Sponsor Securities include Founder Shares, Private Placement Units, promissory notes held by the Sponsor and securities issued or issuable in respect thereof. The Sponsor is subject to specified restrictions on transferring such securities during the option period.

 

Termination

 

The BCA may be terminated by mutual written consent or under specified circumstances, including failure to obtain the required shareholder approval, certain legal prohibitions, uncured material breaches, or failure to consummate the Business Combination by May 26, 2027 (the “Outside Closing Date”). FortuneX may also terminate the BCA if WT Realty fails to deliver the required PCAOB-audited financial statements by October 30, 2026. WT Realty’s PCAOB-audited financial statements were included in the registration statement on Form S-4 filed with the SEC on October 16, 2026, and such termination right was not triggered. Under specified circumstances, a $500,000 termination fee may be payable by the breaching party to the non-breaching party.

 

The BCA was unanimously approved by the boards of directors of FortuneX, WT Realty and Merger Sub. The Business Combination is expected to be consummated following satisfaction or waiver of the applicable closing conditions. There can be no assurance that the Business Combination will be completed.

 

Amendment to Business Combination Agreement

 

On October 13, 2026, FortuneX, WT Realty and Merger Sub entered into a First Amendment to BCA (the “Amendment”). Pursuant to the Amendment, the parties agreed to amend and restate in its entirety the definition of “Aggregate Merger Consideration” in Section 1.1 of the BCA to reduce the aggregate merger consideration payable to WT Realty’s stockholders from 60,000,000 shares of PubCo Common Stock, representing an agreed equity value of $600,000,000, to 52,500,000 shares of PubCo Common Stock, being the number of shares equal to the agreed equity value of WT Realty of $525,000,000 divided by the reference price of $10.00 per share. The Aggregate Merger Consideration remains a fixed number of shares and is not subject to any adjustment for cash, indebtedness, net debt, working capital or any similar item, whether before or after the date of the Amendment, nor to any purchase price adjustment, escrow or holdback. Except as expressly amended by the Amendment, the Business Combination Agreement remains in full force and effect in accordance with its terms.

 

22

 

 

Results of Operations

 

We have neither engaged in any operations nor generated any revenues to date. Our only activities from February 16, 2026 (inception) through September 30, 2026, were organizational activities and those necessary to consummate the IPO, and subsequent to the IPO, identifying a target company for an initial business combination. We do not expect to generate any operating revenues until after the completion of our initial business combination.

 

We expect to generate non-operating income in the form of interest income on marketable securities held after the IPO. We expect to incur increased expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing, a Business Combination.

 

For the three months ended September 30, 2026, we had net income of $407,669, which consisted of general and administrative expenses of $384,781, offset by interest earned on investments held in the Trust Account of $789,873 and bank interest income of $2,577.

 

For the six months ended September 30, 2026, we had net income of $590,380, which consisted of general and administrative expenses of $492,466, offset by interest earned on investments held in the Trust Account of $1,077,010 and bank interest income of $5,836.

 

Liquidity and Capital Resources

 

On May 26, 2026, we consummated our IPO of 7,500,000 units (the “Units”), at $10.00 per Unit. Simultaneously with the closing of our IPO, we consummated the sale of 297,500 Private Placement Units at a price of $10.00 per Private Placement Unit in a private placement to the Sponsor, generating total gross proceeds of $2,975,000.

 

On May 27, 2026, the underwriter fully exercised its over-allotment option to purchase 1,125,000 additional Units for an aggregate of 8,625,000 Units sold. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $86,250,000. The over-allotment option closed on May 29, 2026. Simultaneously with the closing of the over-allotment option, the Company consummated the sale of an additional 15,000 Private Placement Units at a price of $10.00 per unit, generating gross proceeds of $150,000.

 

Upon the closing of the IPO on May 26, 2026 and over-allotment on May 29, 2026, a total of $87,112,500 was placed in a trust account (the “Trust Account”) maintained by Continental Stock Transfer & Trust Company as a trustee and will be invested only in U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended (the “Investment Company Act”), and that invest only in direct U.S. government treasury obligations.

 

We intend to use substantially all of the net proceeds of the IPO and the private placement, including the funds held in the Trust Account, in connection with our initial business combination and to pay our expenses relating thereto. To the extent that our capital stock is used in whole or in part as consideration to effect our initial business combination, the remaining proceeds held in the Trust Account as well as any other net proceeds not expended will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses incurred prior to the completion of our initial business combination if the funds available to us outside of the Trust Account were insufficient to cover such expenses.

 

As of September 30, 2026, we had cash and cash equivalents of $506,057 and working capital of $628,777. In addition, as of September 30, 2026, we had $88,189,510 of investments held in the Trust Account.

 

23

 

 

Net cash used in operating activities for the six months ended September 30, 2026 was $682,866. Net cash used in investing activities was $87,112,500, which was related to the purchase of investments held in the Trust Account. Net cash provided by financing activities was $88,301,423, consisting primarily of proceeds from the IPO and private placements, partially offset by underwriting compensation, offering costs and repayments of related-party advances.

 

The Company has incurred and expects to continue to incur significant costs in pursuit of the consummation of an initial Business Combination. If our estimates of the costs of undertaking in-depth due diligence and negotiating our initial business combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial business combination. Moreover, we may need to obtain additional financing either to consummate our initial business combination or because we become obligated to redeem a significant number of our public shares upon consummation of our initial business combination, in which case we may issue additional securities or incur debt in connection with such business combination.

 

In addition, the Company currently has until May 26, 2027 (unless the Company extends such period by amending its Amended and Restated Memorandum and Articles of Association) to consummate the initial Business Combination. If the Company does not complete a Business Combination within the prescribed timeline, the Company will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles of Association. In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards “Codification Subtopic 205-40, Presentation of Financial Statements - Going Concern”, the Company has determined that it has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. Management plans to address this uncertainty through the consummation of the Business Combination with WT Realty and, if necessary, additional financing that may be sought from the Sponsor or other sources, although no such financing is assured. However, the consummation of the Business Combination is subject to conditions outside of the Company’s control, including shareholder and regulatory approvals. There is no assurance that the Company’s plans to raise capital or to consummate a Business Combination will be successful within the Combination Period. The Company lacks the financial resources it needs to sustain operations for a reasonable period of time, which is considered to be one year from the date of the issuance of the unaudited condensed consolidated financial statements. Therefore, management has determined that these conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Off-Balance Sheet Arrangements

 

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

 

Contractual Obligations

 

Promissory Note — Related Party

 

On February 28, 2026, the Sponsor agreed to loan the Company up to an aggregate amount of $200,000 to be used, in part, for transaction costs incurred in connection with the IPO (the “Promissory Note”). The Promissory Note is unsecured, interest-free and due on the date on which the Company closes the IPO. The outstanding balance under the Promissory Note was repaid upon the closing of the IPO on May 26, 2026 out of the offering proceeds not held in the Trust Account.

 

24

 

 

Administrative Services Agreement

 

The Company entered into an Administrative Services Agreement with the Sponsor on February 28, 2026, commencing on the effective date of the registration statement of the initial public offering through the earlier of the consummation of a business combination or the Company’s liquidation, to pay the Sponsor a total of $15,000 per month for office space and administrative and support services.

 

Underwriting Agreement

 

We granted Polaris Advisory Partners (“PAP”), the representative of the underwriters, a 45-day option from the date of IPO, to purchase up to 1,125,000 additional Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. The underwriter fully exercised its over-allotment option on May 27, 2026, and the over-allotment option closed on May 29, 2026.

 

Pursuant to the Underwriting Agreement, as amended by Amendment No. 1 to the Underwriting Agreement, PAP is entitled to an underwriting discount of 0.33% of the gross proceeds of the IPO, which was paid upon the closing of the IPO, and a deferred underwriting fee equal to 5.0% of the gross proceeds of the IPO, which is payable upon the consummation of the Company’s initial Business Combination from the amounts remaining in the Trust Account, subject to the terms of the Underwriting Agreement.

 

Right of First Refusal

 

We granted PAP a right of first refusal for a period commencing from the consummation of the IPO until the earlier of (i) 10 months after the consummation of the initial business combination (or the liquidation of the Trust Account in the event that the Company fails to consummate its initial business combination within the prescribed time period) or (ii) 36 months after the consummation of the IPO in accordance with FINRA Rule 5110(g)(6)(A) to act as lead financial advisor, capital markets advisor, underwriter and/or private placement agent in connection with any initial business combination or in connection with any financing that occurs between the closing of the IPO and the date that is the earlier of (i) 10 months after the closing of the initial business combination or (ii) 36 months after the consummation of the IPO.

 

Critical Accounting Policies and Estimates

 

The preparation of unaudited financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have not identified any critical accounting policies and estimates.

 

Recent Accounting Standards

 

In November 2024, the FASB issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses”, requiring public entities to disclose additional information about specific expense categories in the notes to the unaudited financial statements on an interim and annual basis. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

 

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

 

25

 

 

Off-Balance Sheet Arrangements; Commitments and Contractual Obligations; Quarterly Results

 

As of September 30, 2026, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K. Other than the administrative services agreement and other arrangements disclosed elsewhere in this report, we did not have any material commitments or contractual obligations.

 

JOBS Act

 

On April 5, 2012, the JOBS Act was signed into law. The JOBS Act contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

 

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions, we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not required for smaller reporting companies.

 

Item 4. Controls and Procedures.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

26

 

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management including our Chief Executive Officer, Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Our Chief Executive Officer and Chief Financial Officer carried out an evaluation with the participation of management of the effectiveness of our disclosure controls and procedures as of the end of the quarter ended September 30, 2026, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that during the period covered by this report, our disclosure controls and procedures were ineffective.

 

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Inherent Limitations on Effectiveness of Internal Controls

 

A control system, no matter how well designed and operated, can provide only reasonable and not absolute assurance of achieving the desired control objectives. In reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs. In addition, the design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

 

27

 

 

PART II – OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

There is no material litigation, arbitration or governmental proceeding currently pending against us or any members of our management team in their capacity as such.

 

Item 1A. Risk Factors.

 

As a smaller reporting company, we are not required to make disclosures under this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On February 28, 2026, the Sponsor acquired an aggregate of 3,694,429 founder shares for an aggregate purchase price of $25,000. Following the full exercise of the underwriters’ over-allotment option, no founder shares are subject to forfeiture. Accordingly, the Sponsor currently holds 3,694,429 founder shares.

 

On May 26, 2026, the Company consummated its initial public offering (the “IPO”) of 7,500,000 units (the “Units”). Each Unit consists of one ordinary share and one-half of one redeemable warrant. The Units were sold at an offering price of $10.00 per Unit, generating total gross proceeds of $75,000,000. On May 27, 2026, the underwriters exercised their over-allotment option in full, resulting in the issuance of an additional 1,125,000 Units at $10.00 per Unit, generating additional gross proceeds of $11,250,000. The over-allotment option closed on May 29, 2026.

 

Simultaneously with the consummation of the IPO and the sale of the Units, the Company consummated the private placement (the “Private Placement”) of 297,500 Units (the “Private Placement Units”), each Private Placement Unit consisting of one Ordinary Share and one-half of one redeemable warrant, to the Sponsor at a price of $10.00 per Private Placement Unit, generating total gross proceeds of $2,975,000. Upon the closing of the over-allotment option, the Company consummated an additional private placement of 15,000 private placement units, generating gross proceeds of $150,000.

 

Following the closing of our IPO, an aggregate of $87,112,500 from the net proceeds of the IPO and the sale of the Private Placement Units was held in the Trust Account.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not Applicable.

 

Item 5. Other Information.

 

None.

 

28

 

 

Item 6. Exhibits.

 

Exhibit No.   Description
31.1   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS*   Inline XBRL Instance Document
101.SCH*   Inline XBRL Taxonomy Extension Schema Document
101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

29

 

 

SIGNATURES

 

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: November 16, 2026

 

  FortuneX Acquisition Corporation
   
  By: /s/ Daniel M. McCabe
  Name:  Daniel M. McCabe
  Title:  Chief Executive Officer and Chairman
    (Principal Executive Officer, Principal Financial and Accounting Officer)

 

30

Keep reading